{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:42:44Z","timestamp":1785796964580,"version":"3.56.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background and purpose: To identify patients with oral cancer (OC) who benefit from proton therapy versus photon therapy using a model-based approach (MBA) to reduce late adverse events. Material\/Methods: Passive scattering proton beam therapy (PSPT) and volumetric modulated arc therapy (VMAT) plans were established for 40 patients with OC, consisting of a dose of 70\u00a0Gy (relative biological effectiveness) in 35 fractions. At least 95% of the planning target volume received 95% of the prescribed dose, and the dose to the organs at risk was restricted to be as low as possible. Normal tissue complication probability (NTCP) was used to estimate the risk of late adverse events, including dysgeusia, xerostomia and osteoradionecrosis of the mandible. Patients who were considered as candidates for PSPT were selected if the NTCP difference between both plans (\u0394NTCP) exceeded the threshold defined in the Dutch national indication protocol. Results: PSPT reduced the doses to the spinal cord, pharynx, oral cavity and contralateral salivary glands compared with VMAT. PSPT was also superior for the risk evaluation of each late adverse event calculated by incorporating dose metrics and patient baseline risk factors. For the MBA using \u0394NTCP and the thresholds, PSPT was indicated in 24 of the 40 cases, and the remaining 16 cases were considered to be equivalent to VMAT. Conclusion: MBA was used to select OC cases that were candidates for PSPT. Compared with VMAT, the risk of expected late adverse events was significantly reduced with PSPT, and 60% of patients were considered eligible for PSPT.<\/jats:p>","DOI":"10.1093\/jrr\/rrag042","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T11:31:11Z","timestamp":1778412671000},"page":"626-633","source":"Crossref","is-referenced-by-count":1,"title":["A model-based selection of oral cancer patient for passive scattering proton beam therapy"],"prefix":"10.1093","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-6376","authenticated-orcid":false,"given":"Yuki","family":"Narita","sequence":"first","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center , 7-172 Yatsuyamada, Koriyama, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Takayama","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku Proton Therapy Center , 7-172 Yatsuyamada, Koriyama, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8343-8037","authenticated-orcid":false,"given":"Takahiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center , 7-172 Yatsuyamada, Koriyama, Fukushima 963-8052 ,","place":["Japan"]},{"name":"Department of Radiological Sciences, School of Health Sciences, Fukushima Medical University , 10-6 Sakaemachi, Fukushima, Fukushima 960-8516 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-9416","authenticated-orcid":false,"given":"Shinya","family":"Komori","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center , 7-172 Yatsuyamada, Koriyama, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Seto","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku Proton Therapy Center , 7-172 Yatsuyamada, Koriyama, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Nakasato","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku Proton Therapy Center , 7-172 Yatsuyamada, Koriyama, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-0337","authenticated-orcid":false,"given":"Masao","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku Proton Therapy Center , 7-172 Yatsuyamada, Koriyama, Fukushima 963-8052 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"2026072501212899300_ref1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.coms.2018.08.002","article-title":"Oral cavity cancer","volume":"31","author":"Ettinger","year":"2019","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"2026072501212899300_ref2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.oraloncology.2008.05.017","article-title":"Current concepts in management of oral cancer surgery","volume":"45","author":"Shah","year":"2009","journal-title":"Oral Oncol"},{"key":"2026072501212899300_ref3","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/lary.24079","article-title":"Outcome predictors in squamous cell carcinoma of the maxillary alveolus and hard plate","volume":"123","author":"Eskander","year":"2013","journal-title":"Laryngoscope"},{"key":"2026072501212899300_ref4","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"2026072501212899300_ref5","doi-asserted-by":"crossref","first-page":"e2151","DOI":"10.1002\/hed.24026","article-title":"Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: a systematic review","volume":"38","author":"Strojan","year":"2016","journal-title":"Head Neck"},{"key":"2026072501212899300_ref6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.oraloncology.2018.02.002","article-title":"Chemoradiotherapy using retrograde superselective intra-arterial infusion for tongue cancer: analysis of therapeutic results in 118 cases","volume":"79","author":"Mitsudo","year":"2018","journal-title":"Oral Oncol"},{"key":"2026072501212899300_ref7","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/1097-0142(20001115)89:10<2099::AID-CNCR10>3.0.CO;2-4","article-title":"A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Phase I study","volume":"89","author":"Fuwa","year":"2000","journal-title":"Cancer"},{"key":"2026072501212899300_ref8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3109\/00016489.2015.1040171","article-title":"The efficacy of superselective intra-arterials infusion with concomitant radiotherapy for adenoid cystic carcinoma of the head and neck","volume":"135","author":"Homma","year":"2015","journal-title":"Acta Otolaryngol"},{"key":"2026072501212899300_ref9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-717X-8-26","article-title":"Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head-and-neck cancer: a planning study","volume":"8","author":"Holt","year":"2013","journal-title":"Radiat Oncol"},{"key":"2026072501212899300_ref10","doi-asserted-by":"crossref","first-page":"4998997","DOI":"10.1155\/2022\/4998997","article-title":"Dosimetric comparison between volumetric modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) for dental structure of head and neck cancer patients","volume":"2022","author":"Ma","year":"2022","journal-title":"J Healthc Eng"},{"key":"2026072501212899300_ref11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/jnci\/84.3.155","article-title":"Proton beams in radiation therapy","volume":"84","author":"Suit","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"2026072501212899300_ref12","first-page":"376","article-title":"Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer","volume":"101","author":"Simone","year":"2011","journal-title":"Radiat Oncol"},{"key":"2026072501212899300_ref13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semradonc.2017.11.008","article-title":"Clinical trial strategies to compare protons with photons","volume":"28","author":"Langendijk","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"2026072501212899300_ref14","doi-asserted-by":"crossref","first-page":"109812","DOI":"10.1016\/j.radonc.2023.109812","article-title":"Evaluation of decentralized model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35","volume":"190","author":"Hansen","year":"2024","journal-title":"Radiother Oncol"},{"key":"2026072501212899300_ref15","doi-asserted-by":"crossref","first-page":"109958","DOI":"10.1016\/j.radonc.2023.109958","article-title":"Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer","volume":"190","author":"Friborg","year":"2024","journal-title":"Radiother Oncol"},{"key":"2026072501212899300_ref16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.radonc.2020.07.056","article-title":"First experience with model-based selection of head and neck cancer patients for proton therapy","volume":"151","author":"Tambas","year":"2020","journal-title":"Radiother Oncol"},{"key":"2026072501212899300_ref17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0360-3016(00)01555-8","article-title":"Methodologies and tools for proton beam design for lung tumors","volume":"49","author":"Moyers","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026072501212899300_ref18","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026072501212899300_ref19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2016.05.011","article-title":"Predictors of dysgeusia in patients with oropharyngeal cancer treated with chemotherapy and intensity modulated radiation therapy","volume":"96","author":"Sapir","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026072501212899300_ref20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","article-title":"NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"key":"2026072501212899300_ref21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijrobp.2021.04.042","article-title":"Normal tissue complication probability (NTCP) prediction model for osteoradionecrosis of the mandible in patients with head and neck cancer after radiation therapy: large-scale observational cohort","volume":"111","author":"Van Dijk","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026072501212899300_ref22","doi-asserted-by":"crossref","first-page":"109670","DOI":"10.1016\/j.radonc.2023.109670","article-title":"Proton arc therapy increases the benefit of proton therapy for oropharyngeal cancer patients in the model-based clinic","volume":"184","author":"De Jong","year":"2023","journal-title":"Radiother Oncol"},{"key":"2026072501212899300_ref23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ijrobp.2015.04.031","article-title":"Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis","volume":"92","author":"Jakobi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026072501212899300_ref24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2018.12.055","article-title":"A model-based approach to predict short-term toxicity benefits with proton therapy for oropharyngeal cancer","volume":"104","author":"Rwigema","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026072501212899300_ref25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026072501212899300_ref26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.radonc.2021.02.034","article-title":"Model based patient pre-selection for intensity-modulated proton therapy (IMPT) using automated treatment planning and machine learning","volume":"158","author":"Kouwenberg","year":"2021","journal-title":"Radiother Oncol"},{"key":"2026072501212899300_ref27","first-page":"150","article-title":"Training and validation of a knowledge-based dose-volume histogram predictive model in the optimization of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients","volume":"27","author":"Franceschini","year":"2022","journal-title":"Radiother Oncol"},{"key":"2026072501212899300_ref28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1748-717X-9-202","article-title":"A single-field integrated boost treatment planning technique for spot scanning proton therapy","volume":"11","author":"Zhu","year":"2014","journal-title":"Radiat Oncol"},{"key":"2026072501212899300_ref29","doi-asserted-by":"crossref","first-page":"081709","DOI":"10.1118\/1.4813900","article-title":"Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer","volume":"40","author":"Quan","year":"2013","journal-title":"Med Phys"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/67\/4\/626\/68475932\/rrag042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/67\/4\/626\/68475932\/rrag042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:21:36Z","timestamp":1784956896000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/67\/4\/626\/8702478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6,4]]},"published-print":{"date-parts":[[2026,7,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rrag042","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,6,4]]}}}